Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies

BACKGROUND: Convalescent plasma is one of the treatment options for COVID-19 which is currently being investigated in many clinical trials. Understanding of donor and product characteristics is important for optimization of convalescent plasma. METHODS: Patients who had recovered from CO­VID-19 were...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transfus Med Hemother
Auteurs principaux: Körper, Sixten, Jahrsdörfer, Bernd, Corman, Victor M., Pilch, Jan, Wuchter, Patrick, Blasczyk, Rainer, Müller, Rebecca, Tonn, Torsten, Bakchoul, Tamam, Schäfer, Richard, Juhl, David, Schwarz, Tatjana, Gödecke, Nina, Burkhardt, Thomas, Schmidt, Michael, Appl, Thomas, Eichler, Hermann, Klüter, Harald, Drosten, Christian, Seifried, Erhard, Schrezenmeier, Hubert
Format: Artigo
Langue:Inglês
Publié: S. Karger GmbH 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216018/
https://ncbi.nlm.nih.gov/pubmed/34177417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515610
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires